Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Campbell, Danielle M
Redman, Sally
Jorm, Louisa
Cooke, Margaret
Zwi, Anthony B
and
Rychetnik, Lucie
2009.
Increasing the use of evidence in health policy: practice and views of policy makers and researchers.
Australia and New Zealand Health Policy,
Vol. 6,
Issue. 1,
Simoens, Steven
2010.
Use of Economic Evaluation in Decision Making.
Drugs,
Vol. 70,
Issue. 15,
p.
1917.
La Torre, Giuseppe
Nicolotti, Nicola
de Waure, Chiara
and
Ricciardi, Walter
2011.
Development of a weighted scale to assess the quality of cost-effectiveness studies and an application to the economic evaluations of tetravalent HPV vaccine.
Journal of Public Health,
Vol. 19,
Issue. 2,
p.
103.
Nielsen, Camilla PalmhøJ
Funch, Tina Maria
and
Kristensen, Finn Børlum
2011.
Health technology assessment: Research trends and future priorities in Europe.
Journal of Health Services Research & Policy,
Vol. 16,
Issue. 2_suppl,
p.
6.
Langer, Astrid
Holle, Rolf
and
John, Jürgen
2012.
Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.
BMC Health Services Research,
Vol. 12,
Issue. 1,
Langer, Astrid
2012.
A framework for assessing Health Economic Evaluation (HEE) quality appraisal instruments.
BMC Health Services Research,
Vol. 12,
Issue. 1,
Yao, Qiang
Lyu, Peng-Hui
Yang, Lian-Ping
Yao, Lan
and
Liu, Zhi-Yong
2014.
Current performance and future trends in health care sciences and services research.
Scientometrics,
Vol. 101,
Issue. 1,
p.
751.
Sullivan, Shannon M.
Wells, George
and
Coyle, Doug
2015.
What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic Review.
Value in Health,
Vol. 18,
Issue. 6,
p.
915.
Griffiths, Ulla Kou
Legood, Rosa
and
Pitt, Catherine
2016.
Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?.
Health Economics,
Vol. 25,
Issue. S1,
p.
29.
Wranik, W. Dominika
Gambold, Liesl
Hanson, Natasha
and
Levy, Adrian
2017.
The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?.
The International Journal of Health Planning and Management,
Vol. 32,
Issue. 2,
p.
e232.
Duarte, Rui V.
Lambe, Tosin
Raphael, Jon H.
Eldabe, Sam
and
Andronis, Lazaros
2018.
Intrathecal Drug Delivery Systems for the Management of Chronic Noncancer Pain: A Systematic Review of Economic Evaluations.
Pain Practice,
Vol. 18,
Issue. 5,
p.
666.
Sanabria, Andrea Juliana
Kotzeva, Anna
Selva Olid, Anna
Pequeño, Sandra
Vernooij, Robin W.M.
Martínez García, Laura
Zhang, Yuan
Solà, Ivan
Thornton, Judith
and
Alonso-Coello, Pablo
2019.
Most guideline organizations lack explicit guidance in how to incorporate cost considerations.
Journal of Clinical Epidemiology,
Vol. 116,
Issue. ,
p.
72.
Merlo, Gregory
Page, Katie
Zardo, Pauline
and
Graves, Nicholas
2019.
Applying an Implementation Framework to the Use of Evidence from Economic Evaluations in Making Healthcare Decisions.
Applied Health Economics and Health Policy,
Vol. 17,
Issue. 4,
p.
533.
Nguyen, Tan Minh
Tonmukayakul, Utsana
Le, Long Khanh-Dao
Calache, Hanny
and
Mihalopoulos, Cathrine
2023.
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review.
Applied Health Economics and Health Policy,
Vol. 21,
Issue. 1,
p.
53.